Skip to main content

Selecta Biosciences Inc. Common Stock (SELB)

About The Company

SELB Stock Market Logo

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

IPO Year Sector Industry
2016 Health Care Biotechnology: Pharmaceutical Preparations

Selecta Biosciences Inc. (SELB) Latest News

Company Contact & Address (SELB)

Corporate Headquarters Phone Website
United States
+1 617 923-1400 Official SELB Website

SELB Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ SELB

Jobs & Employment at Selecta Biosciences Inc.

LinkedIn Company Page
Official Career & Employment Page Careers & Employment at Selecta Biosciences Inc. (SELB)

Related & Similar Stock Symbols

RCMT Stock Market Price & News


RCM Technologies Inc. Common Stock

IBER Stock Market Price & News


Ibere Pharmaceuticals Class A Ordinary Shares

VIA Stock Market Price & News


Via Renewables Inc. Class A Common Stock